- ECHA
- Konsultationen
- Konsultation betreffend potenziell zu ersetzende Stoffe
- Potenziell zu ersetzender Stoff bisherige Konsultationen
Potenziell zu ersetzender Stoff bisherige Konsultationen
Potenziell zu ersetzender Stoff bisherige Konsultationen
Some consultations on potential candidates for substitution have already taken place and have now been closed. The non-confidential information received in the previous consultations is published in the table below, starting with the most recent consultations. Please note that the information that has been declared confidential is not published but reserved for use only by the Biocidal Products Committee (BPC) members, the ECHA Secretariat and the European Commission.
There are currently no ongoing consultations.
(RS)-α-cyano-3-phenoxybenzyl (1RS,3RS;1RS,3SR)-2,2-dimethyl-3-(2-methylprop-1-enyl) cyclopropanecarboxylate (Cyphenothrin) | 18 | 254-484-5 | 39515-40-7 | 20/06/2017 | Details | |
2,2-dibromo-2-cyanoacetamide (DBNPA) | 4 | 233-539-7 | 10222-01-2 | 18/01/2019 | Details | |
5-Chloro-2-(4-chlorophenoxy)-phenol (DCPP) | 1, 2, 4 | 429-290-0 | 3380-30-1 | 10/06/2014 | Details | |
Clothianidin | 18 | 433-460-1 | 210880-92-5 | 11/04/2014 | Details | |
Cyfluthrin | 18 | 269-855-7 | 68359-37-5 | 11/04/2014 | Details | |
Dinotefuran | 18 | - | 165252-70-0 | 28/01/2014 | Details | |
Polyhexamethylene biguanide with a mean number-average molecular weight (Mn) of 1600 and a mean polydispersity (D) of 1.8 (PHMB with Mn = 1600 and D = 1.8) | 5 | - |
27083-27-8 32289-58-0 |
21/04/2016 | Details | |
Triclosan | 1 | 222-182-2 | 3380-34-5 | 15/08/2014 | Details | |
Formaldehyde | 2, 3 | 200-001-8 | 50-00-0 | 10/04/2015 | Details | |
Polyhexamethylene biguanide with a mean number-average molecular weight (Mn) of 1600 and a mean polydispersity (D) of 1.8 (PHMB with Mn = 1600 and D = 1.8) | 01, 02, 03, 04, 06, 09, 11 | - | 27083-27-8 | 10/04/2015 | Details | |
Hexaflumuron (ISO),1-(3,5-dichloro-4-(1,1,2,2-tetrafluoroethoxy)phenyl)-3-(2,6-difluorobenzoyl)urea | PT18 | 401-400-1 | 86479-06-3 | 15/10/2021 |
|
Details |
Dinotefuran | PT 18 | 605-399-0 | 165252-70-0 | 04/01/2024 |
|
Details |
Boric acid | 8 | 233-139-2 | 10043-35-3 | 27/10/2020 | Details | |
Carbendazim | 7, 9, 10 | 234-232-0 | 10605-21-7 | 02/09/2014 | Details | |
Cholecalciferol | PT 14 | 200-673-2 | 67-97-0 | 07/11/2023 |
|
Details |
Creosote | 8 | 232-287-5 | 8001-58-9 | 22/12/2019 | Details | |
Cyanamide | 3 and 18 | 206-992-3 | 420-04-2 | 25/08/2019 | Details | |
2,2-dibromo-2-cyanoacetamide (DBNPA) | PT 6 | 233-539-7 | 10222-01-2 | 25/03/2023 |
|
Details |
Disodium tetraborate pentahydrate | 8 | 215-540-4 | 12179-04-3 | 27/10/2020 | Details | |
Glutaral,Glutaraldehyde,1,5-pentanedial | 02, 03, 04, 06, 11, 12 | 203-856-5 | 111-30-8 | 15/02/2014 | Details | |
Medetomidine | 21 | - | 86347-14-0 | 15/08/2014 |
|
Details |
Medetomidine (RS)-4-[1-(2,3-dimethylphenyl)ethyl]-1H-imidazole (Racemic) |
PT 21 | - | 86347-14-0 | 04/01/2024 |
|
Details |
1-[[2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolan-2-yl]methyl]-1H-1,2,4-triazole (Propiconazole) | PT 8 | 262-104-4 | 60207-90-1 | 06/09/2021 |
|
Details |
Acetamiprid | 18 | - |
135410-20-7 160430-64-8 |
17/01/2017 | Details | |
Alpha-bromadiolone ≥ 76.9% 3-[(1R,3R)-(1S,3S)-3-(4′-bromobiphenyl-4-yl)-3-hydroxy-1-phenylpropyl]-4-hydroxycoumarin and ≤ 23.1% 3-[(1R, 3S)-(1S,3R)-3-(4′-bromobiphenyl-4-yl)-3-hydroxy-1-phenylpropyl]-4-hydroxycoumarin |
PT 14 | - | - | 14/04/2020 | Details | |
Brodifacoum | 14 | 259-980-5 | 56073-10-0 | 15/02/2016 | Details | |
Bromadiolone | 14 | 249-205-9 | 28772-56-7 | 15/02/2016 | Details | |
Chlorophacinone | 14 | 223-003-0 | 3691-35-8 | 15/02/2016 | Details | |
Coumatetralyl | 14 | 227-424-0 | 5836-29-3 | 15/02/2016 | Details | |
Difenacoum | 14 | 259-978-4 | 56073-07-5 | 15/02/2016 | Details | |
Difethialone | 14 | - | 104653-34-1 | 15/02/2016 | Details | |
Flocoumafen | 14 | 421-960-0 | 90035-08-8 | 15/02/2016 | Details | |
Warfarin | 14 | 201-377-6 | 81-81-2 | 15/02/2016 | Details | |
Azoxystrobin | 7, 9, 10 | - | 131860-33-8 | 10/04/2017 | Details | |
Chlorfenapyr | 18 | - | 122453-73-0 | 20/06/2017 | Details | |
Chlorophene | 2, 3 | 204-385-8 | 120-32-1 | 10/04/2017 | Details | |
Cholecalciferol (Vitamin D3) | 14 | 200-673-2 | 67-97-0 | 15/09/2017 | Details | |
α,α′,α″-trimethyl-1,3,5-triazine-1,3,5(2H,4H,6H)-triethanol (HPT) [In the RAC Opinion on the CLH proposal for HPT the following name was used: Reaction product of paraformaldehyde and 2-hydroxypropylamine (ratio 1:1)] | 2, 6, 11 and 13 | 246-764-0 | 25254-50-6 | 03/01/2017 | Details | |
Cyanamide | 3, 18 | 206-992-3 | 420-04-2 | 21/04/2016 | Details | |
Cybutryne | 21 | 248-872-3 | 28159-98-0 | 11/04/2014 | Details | |
d-Allethrin | 18 | - | 231937-89-6 | 10/04/2017 | Details | |
Didecylmethylpoly(oxyethyl)ammonium propionate | 8 | - | 94667-33-1 | 11/04/2014 | Details | |
esbiothrin/ d-trans-allethrin 75/25 | 18 | - | 260359-57-7 | 10/04/2017 | Details | |
Ethylene oxide | PT 2 | 200-849-9 | 75-21-8 | 08/06/2020 | Details | |
Hexaflumuron (ISO),1-(3,5-dichloro-4-(1,1,2,2-tetrafluoroethoxy)phenyl)-3-(2,6-difluorobenzoyl)urea | 18 | 401-400-1 | 86479-06-3 | 11/04/2014 | Details | |
N,N'-methylenebismorpholine (MBM) | 6 and 13 | 227-062-3 | 5625-90-1 | 11/04/2014 | Details | |
3,3’-methylene-bis[5-methyloxazolidine] (Oxazolidin/MBO) [In the RAC Opinion on the CLH proposal for MBO the following name was used: Reaction product of paraformaldehyde and 2-hydroxypropylamine (ratio 3:2)] | 2, 6, 11, 12 and 13 | 266-235-8 | 66204-44-2 | 03/01/2017 | Details | |
PHMB (1415; 4.7) i.e. Polyhexamethylene biguanide with a mean number-average molecular weight (Mn) of 1415 and a mean polydispersity (PDI) of 4.7 | 1, 2, 4, 5, 6 | - |
32289-58-0 1802181-67-4 |
10/04/2017 | Details | |
N-Didecyl-N-dipolyethoxyammonium borate/Didecylpolyoxethylammonium borate (Polymeric betaine) | PT 8 | - | 214710-34-6 | 04/01/2024 |
|
Details |
2-methyl-4-oxo-3-(prop-2-ynyl)cyclopent-2-en-1-yl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate (Prallethrin) | PT 18 | 245-387-9 | 23031-36-9 | 22/01/2024 |
|
Details |